# 2025-19709: Advanced Nurse Hit with DEA Decision on Drug Authority

2025-19709, Tracy Amerson-Rivers, A.P.R.N.; Decision and Order, is a Federal Register notice from Justice Department, Drug Enforcement Administration published 2025-10-30, effective 2025-12-01 (as of 2026-06-08).

- Canonical: https://policyrisk.com/federal-register/2025-19709
- As of: 2026-06-08
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2025-19709
- Title: Tracy Amerson-Rivers, A.P.R.N.; Decision and Order
- Type: Notice
- Agencies: Justice Department; Drug Enforcement Administration
- Citation: 90 FR 48884
- Published: 2025-10-30
- Effective: 2025-12-01
- Comments close: not stated
- Significant: no
- Touches household money: no
- Regulation identifier numbers: none
- Last updated: 2026-06-08

## In one line

Advanced Nurse Hit with DEA Decision on Drug Authority

## Summary

Tracy Amerson-Rivers, an advanced practice nurse from Texas, had her DEA registration suspended and then revoked because she prescribed controlled drugs without the required doctor’s approval and was accused of fraud. This means she can no longer legally prescribe these medications, protecting public safety. The revocation is final, even though her registration expired in June 2025, and it sends a clear message about following the rules.

## Effects PRIA read

- DEA Registration Revoked — No Prescribing: benefit, low. The DEA revoked Tracy Amerson-Rivers' Certificate of Registration No. MA5242792, effective December 1, 2025, so she can no longer legally prescribe controlled substances. The Agency found she issued six controlled-substance prescriptions without prescriptive authority between March 5, 2023 and Apri…
- Renewal and New Registrations Denied: benefit, low. The Order also denies any pending applications by Tracy Amerson-Rivers to renew or modify registration No. MA5242792 and denies any other pending application of hers for additional registration in Texas. The record shows her DEA registration had expired on June 30, 2025, and the denial accompanies…

## Related documents

- [2026-11526](https://policyrisk.com/federal-register/2026-11526): Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 201…, 2026-06-09
- [2026-10128](https://policyrisk.com/federal-register/2026-10128): Revision of Applications for Manufacturing and Procurement Quotas, 2026-05-20
- [2025-05007](https://policyrisk.com/federal-register/2025-05007): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-03-24
- [2025-02793](https://policyrisk.com/federal-register/2025-02793): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-02-19
- [2026-22843](https://policyrisk.com/federal-register/2026-22843): Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ep…, 2026-11-10
- [2026-22842](https://policyrisk.com/federal-register/2026-22842): Adjustment to the 2026 Aggregate Production Quota for d,l-Amphetamine, d-Amphetamine (for Sale), Hydromorphone and Methylphenidate (for Sal…, 2026-11-10

## Sources
- [2025-19709 on federalregister.gov](https://www.federalregister.gov/documents/2025/10/30/2025-19709/tracy-amerson-rivers-aprn-decision-and-order)
- [2025-19709 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2025-10-30/pdf/2025-19709.pdf)

## Related
- [Previous: 2025-19708, Pharmacy Place, Llc; Decision and Order](https://policyrisk.com/federal-register/2025-19708)
- [Next: 2025-19710, Antony Vanbang, M.D.; Decision and Order](https://policyrisk.com/federal-register/2025-19710)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2025-19709 (as of 2026-06-08).
